RHOD expression associates with survival in triple negative breast cancer.

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival following treatment: dead or alive. We observed significant transcriptome-wide differential expression of ras homolog family member D, encoded by RHOD when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, RHOD expression was significantly correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. RHOD may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.

PAX5 expression associates with survival in triple negative breast cancer.

10.31219/osf.io/rh6xb ◽

2021 ◽

Author(s):

Shahan Mamoor

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival following treatment: dead or alive. We observed significant transcriptome-wide differential expression of paired box 5, encoded by PAX5 when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, PAX5 expression was significantly correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. PAX5 may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.

LAX1 expression associates with survival in triple negative breast cancer.

10.31219/osf.io/7mhje ◽

2021 ◽

Author(s):

Shahan Mamoor

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival at time of analysis: dead or alive. We observed significant transcriptome-wide differential expression of lymphocyte transmembrane adaptor 1, encoded by LAX1 when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, LAX1 expression was significantly correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. LAX1 may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.

SELL expression associates with survival in triple negative breast cancer.

10.31219/osf.io/mjvc9 ◽

2021 ◽

Author(s):

Shahan Mamoor

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival at time of analysis: dead or alive. We observed significant transcriptome-wide differential expression of selectin L, encoded by SELL, when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, SELL expression was significantly correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. SELL may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.

RASGRP1 expression associates with survival in triple negative breast cancer.

10.31219/osf.io/m2x3j ◽

2021 ◽

Author(s):

Shahan Mamoor

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival following treatment: dead or alive. We observed significant transcriptome-wide differential expression of RAS guanyl releasing protein 1 (calcium and DAG-regulated), encoded by RASGRP1 when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, RASGRP1 expression was correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. RASGRP1 may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.

TUBA1C expression associates with survival in triple negative breast cancer.

10.31219/osf.io/qytd6 ◽

2021 ◽

Author(s):

Shahan Mamoor

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival following treatment: dead or alive. We observed significant transcriptome-wide differential expression of tubulin, alpha 1c, encoded by TUBA1C when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, TUBA1C expression was correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. TUBA1C may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.

GSR expression associates with survival in triple negative breast cancer.

10.31219/osf.io/unkvz ◽

2021 ◽

Author(s):

Shahan Mamoor

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival following treatment: dead or alive. We observed significant transcriptome-wide differential expression of glutathione reductase, encoded by GSR when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, GSR expression was correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. GSR may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.

PARVG expression associates with survival in triple negative breast cancer.

10.31219/osf.io/78xwk ◽

2021 ◽

Author(s):

Shahan Mamoor

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival at time of analysis: dead or alive. We observed significant transcriptome-wide differential expression of parvin, gamma, encoded by PARVG when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, PARVG expression was significantly correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. PARVG may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.

BAIAP2L1 expression associates with survival in triple negative breast cancer.

10.31219/osf.io/4kx3t ◽

2021 ◽

Author(s):

Shahan Mamoor

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival at time of analysis: dead or alive. We observed significant transcriptome-wide differential expression of BAI1-associated protein 2-like 1, encoded by BAIAP2L1 when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, BAIAP2L1 expression was significantly correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. BAIAP2L1 may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.

CTLA4 expression associates with survival in triple negative breast cancer.

10.31219/osf.io/ngmu8 ◽

2021 ◽

Author(s):

Shahan Mamoor

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival at time of analysis: dead or alive. We observed significant transcriptome-wide differential expression of the T-cell inhibitory co-receptor for the B7 ligand, CTLA4, when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, CTLA4 expression was significantly correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. CTLA4 may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.

PGM2L1 expression associates with survival in triple negative breast cancer.

10.31219/osf.io/fpn9v ◽

2021 ◽

Author(s):

Shahan Mamoor

Keyword(s):

Breast Cancer ◽

Gene Expression ◽

Cancer Patients ◽

Microarray Data ◽

Triple Negative ◽

Molecular Subtype ◽

Breast Cancer Patients ◽

Primary Tumors ◽

We mined published microarray data (1) to understand the most significant gene expression differences in the tumors of triple negative breast cancer patients based on survival following treatment: dead or alive. We observed significant transcriptome-wide differential expression of phosphoglucomutase 2-like 1, encoded by PGM2L1 when comparing the primary tumors of triple negative breast cancer patients dead or alive. Importantly, PGM2L1 expression was correlated with overall survival in basal subtype breast cancer, a molecular subtype sharing significant overlap with triple negative breast cancer. PGM2L1 may be of relevance as a biomarker or as a molecule of interest in understanding the etiology or progression of triple negative breast cancer.